The correlation between biochemical abnormalities in frontal white matter, hippocampus and serum thyroid hormone levels in first-episode patients with major depressive disorder
- PMID: 25913802
- DOI: 10.1016/j.jad.2015.04.005
The correlation between biochemical abnormalities in frontal white matter, hippocampus and serum thyroid hormone levels in first-episode patients with major depressive disorder
Abstract
Background: Previous neuroimaging studies found evidence of potential brain biochemical abnormalities in patients with major depressive disorder (MDD). Abnormal serum thyroid hormone levels were also found in MDD patients, which may correlated with the abnormal biochemical metabolism of brain. However, they rarely excluded the compounding effects of medication, and brain degeneration. This study sought to investigate the relationship between the biochemical metabolism and the serum thyroid hormone levels in first-episode, treatment-naive, non-late-life patients with MDD.
Methods: 26 first-episode, treatment-naive, non-late-life patients with MDD and 13 healthy controls were enrolled in this study. Participants underwent two-dimensinal multivoxel proton magnetic resonance spectroscopy ((1)H MRS) [repetition time (TR)=1000ms; echo-time (TE)=144ms] at 1.5T to obtain bilateral metabolite levels from the white matter in prefrontal (WMP) lobe, anterior cingulate cortex (ACC), and hippocampus. The ratios of N-acetylaspartate (NAA)/creatine (Cr) and choline containg compounds (Cho)/creatine (Cr) were calculated. Morning serum free triiodothyronine (FT3), free thyroxin (FT4), total triiodothyronine (T3), total thyroxin (T4), and thyroid-stimulating hormone (TSH) were measured before antidepressant treatment.
Results: On the comparison of brain biochemical changes, MDD patients had a significantly lower NAA/Cr ratio in the left WMP, and lower NAA/Cr and Cho/Cr ratios in the right WMP when compared to the controls. There were no significant differences in the metabolite ratios in the bilateral ACC, and hippocampus. On the comparison of serum thyroid hormone levels, MDD patients had a significantly decreased T3 and TSH levels. On the comparison of correlation of brain biochemical changes and serum thyroid hormone levels in patients with MDD, the NAA/Cr ratio in the right WMP was positively correlated with the level of TSH.
Conclusion: These findings suggest that biochemical abnormalities and thyroid dysfunction may emerge early in the course of MDD. Dysfunction of neuronal function in the WMP may correlate with the abnormal TSH in patients with MDD, which may be related to the neuropathology of depression.
Keywords: Major depressive disorder; Proton magnetic resonance spectroscopy; Serum thyroid hormone.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.J Affect Disord. 2014 Oct;168:380-6. doi: 10.1016/j.jad.2014.07.024. Epub 2014 Jul 24. J Affect Disord. 2014. PMID: 25106035
-
Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.J Affect Disord. 2012 Feb;136(3):620-6. doi: 10.1016/j.jad.2011.10.020. Epub 2011 Nov 29. J Affect Disord. 2012. PMID: 22129769
-
Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment.J Psychopharmacol. 2012 Nov;26(11):1463-70. doi: 10.1177/0269881112450781. Epub 2012 Jun 15. J Psychopharmacol. 2012. PMID: 22706518 Clinical Trial.
-
Proton magnetic resonance spectroscopy of N-acetyl aspartate in first depressive episode and chronic major depressive disorder: A systematic review and meta-analysis.J Affect Disord. 2024 Jun 15;355:265-282. doi: 10.1016/j.jad.2024.03.150. Epub 2024 Mar 28. J Affect Disord. 2024. PMID: 38554884
-
Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.Neuroimage Clin. 2023;39:103461. doi: 10.1016/j.nicl.2023.103461. Epub 2023 Jun 27. Neuroimage Clin. 2023. PMID: 37406595 Free PMC article. Review.
Cited by
-
Metabolic Imaging in Humans.Top Magn Reson Imaging. 2016 Oct;25(5):223-235. doi: 10.1097/RMR.0000000000000100. Top Magn Reson Imaging. 2016. PMID: 27748708 Free PMC article. Review.
-
Hypothyroidism and Cognitive Disorders during Development and Adulthood: Implications in the Central Nervous System.Mol Neurobiol. 2019 Apr;56(4):2952-2963. doi: 10.1007/s12035-018-1270-y. Epub 2018 Aug 2. Mol Neurobiol. 2019. PMID: 30073507 Review.
-
Metabolomic Changes in Major Depressive Disorder Adolescent Females with or without Suicide Attempts.Curr Neuropharmacol. 2025;23(7):787-799. doi: 10.2174/1570159X23666250122093451. Curr Neuropharmacol. 2025. PMID: 39844402 Free PMC article.
-
The Thr92Ala polymorphism in the type 2 deiodinase gene is linked to depression in patients with COVID-19 after hospital discharge.Front Endocrinol (Lausanne). 2024 Jun 7;15:1366500. doi: 10.3389/fendo.2024.1366500. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38911040 Free PMC article.
-
Cellular metabolism changes in bilateral hippocampi in patients with herpes zoster.Am J Transl Res. 2022 Jun 15;14(6):3980-3987. eCollection 2022. Am J Transl Res. 2022. PMID: 35836895 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources